Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled Study

BACKGROUND: Immunogenicity of tumor necrosis factor alpha inhibitors (TNFis) has been recognized as an important problem that may cause loss of efficacy and adverse events such as infusion reactions. TNFis are being increasingly used among patients with Behçet syndrome (BS) and scarce data exist on...

Full description

Saved in:
Bibliographic Details
Published in:Front Immunol
Main Authors: Esatoglu, Sinem Nihal, Akkoc-Mustafayev, Fatma Nihan, Ozguler, Yesim, Ozbakır, Fatma, Nohut, Okan K., Cevirgen, Dilsen, Hamuryudan, Vedat, Hatemi, Ibrahim, Celik, Aykut Ferhat, Yazici, Hasan, Hatemi, Gulen
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2020
Subjects:
Immunology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7782473/
https://ncbi.nlm.nih.gov/pubmed/33414791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.618973
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items